ArticleHepatology (Baltimore, Md.)2022

Breviscapine alleviates NASH by inhibiting TGF-β-activated kinase 1-dependent signaling.

Tian Lan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.